Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope (Q45404616)

14 December 2017

title

Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope (English)

1 reference

14 December 2017

1 reference

8

Stanislas Pol

1 reference

14 December 2017

author name string

Silvina Laura Malmassari

1

1 reference

14 December 2017

Qiang Deng

2

1 reference

14 December 2017

Hélène Fontaine

3

1 reference

14 December 2017

Dianne Houitte

4

1 reference

14 December 2017

François Rimlinger

5

1 reference

14 December 2017

Valérie Thiers

6

1 reference

14 December 2017

Bernard Maillere

7

1 reference

14 December 2017

Marie-Louise Michel

9

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

14 December 2017

1 reference

14 December 2017

volume

45

1 reference

14 December 2017

issue

5

1 reference

14 December 2017

page(s)

1199-1209

1 reference

Cellular immune responses to the hepatitis B virus polymerase

14 December 2017

cites work

1 reference

Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

21 January 2018

1 reference

X Gene and Precore Region Mutations in the Hepatitis B Virus Genome in Persons Positive for Antibody to Hepatitis B e Antigen: Comparison between Asymptomatic "Healthy" Carriers and Patients with Severe Chronic Active Hepatitis

21 January 2018

1 reference

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

7 January 2021

Hepatitis B virus infection--natural history and clinical consequences

1 reference

7 January 2021

The enigmatic X gene of hepatitis B virus

1 reference

7 January 2021

Hepatitis B virus X protein: a multifunctional viral regulator

1 reference

7 January 2021

High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers.

1 reference

7 January 2021

Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas

1 reference

7 January 2021

Specific mutations of hepatitis B virus in plasma predict liver cancer development

1 reference

7 January 2021

HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers

1 reference

7 January 2021

Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection.

1 reference

7 January 2021

Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus

1 reference

7 January 2021

Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.

1 reference

7 January 2021

Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis

1 reference

7 January 2021

Cytotoxic T cells and viral hepatitis

1 reference

7 January 2021

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection

1 reference

7 January 2021

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

1 reference

7 January 2021

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

7 January 2021

Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?

1 reference

7 January 2021

Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.

1 reference

7 January 2021

HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo

1 reference

7 January 2021

Immune response of peripheral blood mononuclear cells to HBx-antigen of hepatitis B virus

1 reference

7 January 2021

Management of hepatitis B: 2000--summary of a workshop

1 reference

7 January 2021

Complementarity and redundancy of the binding specificity of HLA-DRB1, -DRB3, -DRB4 and -DRB5 molecules

1 reference

7 January 2021

HLA-DR restricted peptide candidates for bee venom immunotherapy

1 reference

7 January 2021

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

1 reference

7 January 2021

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers

1 reference

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

7 January 2021

Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection

1 reference

7 January 2021

Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity

1 reference

7 January 2021

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion

1 reference

7 January 2021

Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of thein vitroantibody response by interferon gamma

1 reference

7 January 2021

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment

1 reference

7 January 2021

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

1 reference

7 January 2021

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

1 reference

7 January 2021

HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B.

1 reference

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

7 January 2021

Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals

1 reference

7 January 2021

Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus.

1 reference

7 January 2021

Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21594

1 reference

release_grm35wc7bvbxtlk2jfhysnvjti

14 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/grm35wc7bvbxtlk2jfhysnvjti

24 November 2022

mapped directly with Wikidata item

1 reference